The Institute for Neurodegenerative Diseases (IND)

IND is committed to the prevention and treatment of diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and Lewy Body Dementia (LBD). We support people at risk for, or already affected by, these conditions and aim to transform clinical care and research.

Reducing risk of Alzheimer’s through lifestyle changes

Dr. Gupta Explains Lifestyle Changes Linked to Cognitive Improvement

New Findings on Fish Oil Supplement Risks

Dr. Gupta’s Journey into Alzheimer's Prevention

Alzheimer’s transmission in recipients of discontinued medical treatment

Are your dietary choices fueling Alzheimer's progression?

The benefits of pets for those 50+ living alone

Strategies to minimize your risk of early-onset dementia

Personalized brain health assessment & research participation opportunity

Association between abdominal fat and brain inflammation

In women with an increased risk of developing Alzheimer’s disease and dementia, individualized hormone replacement therapy may help protect against cognitive decline

Getting less slow-wave sleep as you age may increase your risk of dementia

Emma Heming Willis Interviews Dr. Richard Isaacson on the Importance of Brain Health

Alzheimer's researchers: Simple eye exam may bring brain health into focus

Opinion: Why aren’t doctors telling patients these simple ways to reduce the risk of dementia?

Sleep apnea, lack of deep sleep linked to damage in brain, study says

Access to New Alzheimer’s Drugs Might Depend on Where You Live

Alzheimer’s first signs may appear in your eyes, study finds

Master Mind: Optimizing Brain Health at SXSW

Mediterranean and MIND diets reduced signs of Alzheimer's in brain tissue, study finds

Laxative use may be linked to dementia risk, study says

Dementia risk rises if you live with chronic pain, study says

Study presents unexpected — and complicated — findings on link between alcohol and dementia

New Alzheimer’s Drug Leqembi Will Be Out of Reach for Most Patients

Alzheimer’s drug lecanemab receives accelerated approval amid safety concerns

Our interdisciplinary team consists of clinicians, researchers, scientists, and students from across the country and the globe. Our experts include leaders in neurology, ophthalmology, clinical psychology, and genetics, among specialties.

IND Florida is committed to the prevention and treatment of diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and Lewy Body Dementia (LBD).

The Institute for Neurodegenerative Diseases (IND)

Team

Research

Programs & Education

Newsroom

Join our mailing list